Back to Search
ULLRICH SCHWERTSCHLAG, M.D.
M.D.
Internal Medicine Physician
NPI: 1407960305Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
81959(MA)
Research & Publications (13)
Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease.
PMID 16635225·Am J Gastroenterol·2006
4-observational
Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells.
PMID 16436634·J Mol Diagn·2006
4-observational
A single administration of recombinant human interleukin-12 is associated with increased expression levels of interferon-gamma and signal transducer and activator of transcription in healthy subjects.
PMID 15901746·J Clin Pharmacol·2005
4-observational
A multiple-dose, safety, tolerability, pharmacokinetics and pharmacodynamic study of oral recombinant human interleukin-11 (oprelvekin).
PMID 15386478·Biopharm Drug Dispos·2004
3-trial
K16 expression in uninvolved psoriatic skin: a possible marker of pre-clinical psoriasis.
PMID 15239676·J Cutan Pathol·2004
8-other
The antiparasitic moxidectin: safety, tolerability, and pharmacokinetics in humans.
PMID 14517193·J Clin Pharmacol·2003
3-trial
Randomized, controlled trial of recombinant human interleukin-11 in patients with active Crohn's disease.
PMID 11876692·Aliment Pharmacol Ther·2002
3-trial
Multiple-dose, safety, pharmacokinetics, and pharmacodynamics of a new selective estrogen receptor modulator, ERA-923, in healthy postmenopausal women.
PMID 11831538·J Clin Pharmacol·2002
3-trial
Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling.
PMID 11911124·Pharmacogenomics J·2001
4-observational
Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis.
PMID 11438043·Arthritis Res·2001
3-trial
Preclinical pharmacologic basis for clinical use of rhIL-11 as an effective platelet-support agent.
PMID 11033834·Oncology (Williston Park)·2000
6-review
Mechanism and amelioration of recombinant human interleukin-11 (rhIL-11)-induced anemia in healthy subjects.
PMID 10934673·J Clin Pharmacol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3 STONE RIDGE RD
BEVERLY, MA 01915 - Phone
- (978) 921-5237
Quick Facts
- NPI
- 1407960305
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 13
Are you this provider?
Claim Your Profile